Sun Pharma’s RespiTrack mobile app to boost treatment compliance amongst asthma patients – ETCIO.com


ETCIO.com

Sun Pharma's RespiTrack mobile app to boost treatment compliance amongst asthma patients
ETCIO.com
Patient adherence to medical regimens is a major problem in chronic disease management. And adherence to asthma medication regimens tends to be very poor, with the reported rates of non-adherence to prescribed treatment regimen in India to be in the …
Sun Pharma launches mobile app for asthma patientsFinancial Express
Sun Pharma takes mobile app route to raise disease awareness: Abhay GandhiBusiness Standard

all 3 news articles »

View full post on asthma – Google News

Sun Pharma launches mobile app for asthma patients – Financial Express


ETCIO.com

Sun Pharma launches mobile app for asthma patients
Financial Express
As part of its focus to give boost to treatment compliance amongst Asthma patients by minimising instances of non-adherence and drop-outs in Asthma treatment regime, Sun Pharma Sun Pharma is rolling out India's first unique and innovative mobile …
Sun Pharma's RespiTrack mobile app to boost treatment compliance amongst asthma patientsETCIO.com
Sun Pharma takes mobile app route to raise disease awareness: Abhay GandhiBusiness Standard

all 3 news articles »

View full post on asthma – Google News

FDA expands indication for asthma rescue inhaler to younger patients – Healio

FDA expands indication for asthma rescue inhaler to younger patients
Healio
Teva Pharmaceuticals announced today that the FDA has expanded the indication for its ProAir, RespiClick inhalation powder to include patients with asthma aged 4 to 11 years, according to a press release.
Teva Pharma (TEVA) Receives FDA Approval for ProAir RespiClick for Pediatric Asthma Patients Ages 4 to 11StreetInsider.com
FDA Expands Breath-Actuated Inhaler Use to Kids as Young as 4Medscape

all 5 news articles »

View full post on asthma – Google News

Teva Pharma (TEVA) Receives FDA Approval for ProAir RespiClick for Pediatric Asthma Patients Ages 4 to 11 – StreetInsider.com

Teva Pharma (TEVA) Receives FDA Approval for ProAir RespiClick for Pediatric Asthma Patients Ages 4 to 11
StreetInsider.com
“The prevalence of childhood asthma in the U.S. is high, at more than six million patients, and that number continues to rise,” said Dr. Erwin Gelfand, Chairman, Department of Pediatrics at National Jewish Health. “For this young population of asthma

and more »

View full post on asthma – Google News

Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients.

Related Articles

Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients.

J Gastroenterol. 2016 Apr 23;

Authors: Jiao D, Ishimura N, Maruyama R, Ishikawa N, Nagase M, Oshima N, Aimi M, Okimoto E, Mikami H, Izumi D, Okada M, Ishihara S, Kinoshita Y

Abstract
BACKGROUND: Esophageal eosinophilia is classified as either eosinophilic esophagitis (EoE) or proton-pump inhibitor-responsive esophageal eosinophilia (PPI-REE), depending on the response to PPI treatment. The aim of this study was to compare the clinical, endoscopic, and histopathological findings of EoE and PPI-REE in Japanese patients. In addition, the characteristics of these cases were compared with those of reflux esophagitis (RE) cases.
METHODS: Eleven patients diagnosed with EoE, 16 with PPI-REE, and 39 with RE, who were all consecutively examined from 2005 to 2015 at Shimane University Hospital, were enrolled. Clinical, endoscopic, and histopathological esophageal findings in these groups were retrospectively examined and compared.
RESULTS: The differences in the clinical characteristics of EoE and PPI-REE were not remarkable, though patients with EoE and PPI-REE were younger, presented a higher prevalence of allergic comorbidities, and complained of symptoms of dysphagia more frequently than those with RE. The only noteworthy differences between EoE and PPI-REE were more frequent reports of asthma (36.4 vs. 2.6 %) and food allergy (27.3 vs. 0 %) by patients with EoE (P < 0.05, P < 0.05, respectively). Endoscopic findings in patients with EoE and PPI-REE were similar, with the presence of esophageal erosions in a small percentage of PPI-REE cases being the only difference. There were no histopathological differences between EoE and PPI-REE.
CONCLUSIONS: Comparisons of clinical, endoscopic, and histopathological findings between EoE and PPI-REE showed that these two types have similar characteristics, though EoE patients showed a higher atopic background. Predicting PPI responsiveness in cases with esophageal eosinophilia is difficult and requires further investigation.

PMID: 27108416 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Allergy & Asthma Network to Advocate for Patients, Access to Care Innovations at Annual Capitol Hill Day on May 12 – PR Newswire (press release)

Allergy & Asthma Network to Advocate for Patients, Access to Care Innovations at Annual Capitol Hill Day on May 12
PR Newswire (press release)
VIENNA, Va., April 25, 2016 /PRNewswire-USNewswire/ — Allergy & Asthma Network will head to Capitol Hill on Thursday, May 12 to advocate for patients and urge Congress to take action on key legislative issues including telehealth services and school …
AAFA's asthma & allergy friendly(TM) Certification Program Celebrates 10 Successful YearsMarketwired (press release)

all 2 news articles »

View full post on asthma – Google News

This new 5-step plan aims to save more asthma patients’ lives – The Press, York


The Press, York

This new 5-step plan aims to save more asthma patients' lives
The Press, York
A YORK Hospital consultant has played a key role in drawing up a national action plan to save asthma patients' lives. John White, a consultant respiratory physician at York NHS Foundation Trust, has helped the British Thoracic Society and Asthma UK

and more »

View full post on asthma – Google News